Literature DB >> 23375379

Biological mechanisms of microvessel formation in advanced atherosclerosis: the big five.

Caroline Cheng1, Ihsan Chrifi, Gerard Pasterkamp, Henricus J Duckers.   

Abstract

Advanced atherosclerotic lesions prone to rupture are characterized by a distinct histomorphology and pathobiology that became in recent years, increasingly related to the process of intraplaque neovascularization. Molecular mechanisms that regulate angiogenesis and that are active in the plaque region may destabilize advanced lesions by promoting microvessel growth and thus providing an entry route for inflammatory cells secondary to the luminal endothelium. In addition, angiogenic factors can also define intraplaque microvessel integrity and endothelial barrier function, determining the prevalence of intraplaque hemorrhaging. Here, we aim to compose a hypothetical model for angiogenic regulation of vulnerable plaque development, based on the evidence of clinical correlation and experimental functional studies that are provided for five of the most well-described angiogenic pathways in the current literature.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375379     DOI: 10.1016/j.tcm.2012.10.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  10 in total

Review 1.  Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.

Authors:  Dongmei Song; Guoqiang Fang; Harly Greenberg; Shu Fang Liu
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  Is Biochemical Follow Up Possible in Peripheral Arterial Disease Treatment: Hypoxia Inducible Factor-1 Alpha?

Authors:  Cihan Yücel; Mete Gürsoy; Serkan Ketenciler; Aslıhan Tenekeciğil; Feryaz Kızıltan; Nihan Kayalar
Journal:  Vasc Specialist Int       Date:  2021-08-25

Review 3.  Heme on innate immunity and inflammation.

Authors:  Fabianno F Dutra; Marcelo T Bozza
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

4.  Lonafarnib is a potential inhibitor for neovascularization.

Authors:  Linlin Sun; Songbo Xie; Guoyuan Peng; Jian Wang; Yuanyuan Li; Juan Qin; Diansheng Zhong
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

5.  A vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability.

Authors:  Héctor De León; Stéphanie Boué; Walter K Schlage; Natalia Boukharov; Jurjen W Westra; Stephan Gebel; Aaron VanHooser; Marja Talikka; R Brett Fields; Emilija Veljkovic; Michael J Peck; Carole Mathis; Vy Hoang; Carine Poussin; Renee Deehan; Katrin Stolle; Julia Hoeng; Manuel C Peitsch
Journal:  J Transl Med       Date:  2014-06-26       Impact factor: 5.531

6.  Cystathionine γ-lyase is expressed in human atherosclerotic plaque microvessels and is involved in micro-angiogenesis.

Authors:  J C van den Born; R Mencke; S Conroy; C J Zeebregts; H van Goor; J L Hillebrands
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

Review 7.  Angiogenesis in the atherosclerotic plaque.

Authors:  Caroline Camaré; Mélanie Pucelle; Anne Nègre-Salvayre; Robert Salvayre
Journal:  Redox Biol       Date:  2017-02-01       Impact factor: 11.799

8.  A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Frédérique Dol-Gleizes; Nathalie Delesque-Touchard; Anne-Marie Marès; Anne-Laure Nestor; Paul Schaeffer; Françoise Bono
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

9.  Silencing of Transient Receptor Potential Channel 4 Alleviates oxLDL-induced Angiogenesis in Human Coronary Artery Endothelial Cells by Inhibition of VEGF and NF-κB.

Authors:  Wen Qin; Wei Xie; Ning Xia; Qinglin He; Tianwei Sun
Journal:  Med Sci Monit       Date:  2016-03-21

Review 10.  Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis.

Authors:  Chloé Turpin; Aurélie Catan; Olivier Meilhac; Emmanuel Bourdon; François Canonne-Hergaux; Philippe Rondeau
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.